Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
  • Bridgeway Large Cap Growth (BRLGX)
    Hi Pop Tart,
    In the LCG space, I prefer POGRX, which continues to produce with a relatively low expense ratio. The Primecap team has produced awesome results over the years at their funds: VPCCX, VPMCX, POAGX, POSKX and POGRX. Unfortunately, only the last two funds are open to new investors. We continue to own a 10% position in POAGX.
    Kevin
  • Biotech price wars coming your way? Many Healthcare funds may be affected.
    It's good to read up on some of this stuff. Healthcare is not and will not always be a straight line upwards. There is an active thread here that touchs on this subject.
    http://www.mutualfundobserver.com/discuss/discussion/17829/express-scripts-abbvie-gilead#latest
    Insurance companies and plans all have what are called Formularies. These are lists of approved drugs from arthritis and headaches to the hepatitis C protocol in the above thread link. When very expensive drug protocols present themselves, organizations will decide which will get the approval. While money is a big part of the decision, other factors such as safety profile and storage considerations play into the decision. In the case described above, Gilead lost out to AbbVie and that has affected Gilead stock in return.
    Biotech drugs are very prone to this kind of treatment. When there are two or three drugs competing for a spot on a major formulary, the decisions can and will have consequences on the stock price.
    This practice of a Formulary is not new, rather it has been around for decades.
  • The Closing Bell: U.S. Stocks Rise; Dow Ends Above 18000
    You heard it first on MFO:
    Tampabay
    December 22 edited December 22 in Off-Topic Flag
    I know better than Saying/thinking this (in this stock market game) BUT we still have time for 18,000 Dow in 2014 (17,895 11:00 am)...who would have thunk it after 2013?
  • Question regarding my SEP-IRA & SEQUX
    I have my SEQUX Roth account held by DST Systems (transfer agent for SEQUX). You have the choice of paying a once a year $12 administrative fee or have the fee deducted from your SEQUX account. I would move the account to the transfer agent rather than sell it.
  • In Defense Of Advisors Who Sell Variable Annuities
    Bob, thanks for your comments.
    Regarding TIAA - I realize you're talking about the fixed portion (TIAA traditional) - the TIAA portion also includes some variable options like TREA as well. The 10 year annuitization requirement is an issue, but strikes me as an apples and oranges comparison. TIAA Traditional is (primarily) available in employer-sponsored plans, while the other plans you mentioned (Schwab, Jeff Nat, etc.) are retail plans.
    I think a more accurate comparison would use TIAA-CREF's after tax product, Intelligent VA. That doesn't offer TIAA Traditional, just as the other plans named don't offer a useful stable value alternative. Thus no issue with 10 year annuitization.
    Over the long term, the fee on Jeff Nat for a $100K account may be higher than TIAA-CREF's. (TIAA-CREF charges 0.35% for ten years, then 0.10%.) But I do agree they're in the same ballpark, and significantly lower than the annuity fee of the other providers.
    Statements really are a problem with TIAA. At least when they produce them. It turns out that for their brokerage accounts, they don't generate 5498s if there have been no contributions, even if the account has RMDs.
    They fault Pershing for this, and I think they may be right - I took a look back at my old Vanguard IRAs; back when it still used Pershing (before about 2010) I did not seem to get 5498s. Now I do.
    As you wrote, nothing is perfect.
  • Express Scripts, AbbVie & Gilead
    Thanks Catch. The bottom line is that my uncle has to take the Abbvie cocktail of pills instead of Gilead's Harvoni pill.
    This conclusion was reached by my uncle's physician, not by Express Scripts as we have still not been able to get through to Express Scripts' horrible customer service. Even though Express Scripts had approved my uncle's Harvoni prescription on Dec. 5 to begin use on Jan. 5, Express Scripts' edict from yesterday stating that they won't cover Harvoni beginning Jan. 1 has forced my uncle to change from a superior cure (Harvoni) to an inferior cure (Abbvie) which includes pills which may cause painful side effects. My uncle's doctor said that he can't get the date of the prescription moved up so that my uncle could begin Harvoni this year.
    It's my sincere hope that Express Scripts is subjected to a massive legal attack costing Express Scripts billions. That would be the best Holiday gift ever!
  • Biotech price wars coming your way? Many Healthcare funds may be affected.
    IMO, keep an eye to this sector; which has had a wonderful run upwards.
    Supposing this would be named one of those "forward looking" thingys in company reports related to their best guess. :)
    ---broad healthcare down -2.5% as of 11am, EST
    several article links via Google Search
    Take care,
    Catch
  • Express Scripts, AbbVie & Gilead
    Hi @PopTart,
    This note was part of a notification related to a pharma stock we currently hold.
    'Course, I don't know if this product (FDA approved on Dec. 19) would relate to your uncle's circumstance.
    short article link
    Take care of you and yours at A-squared, and enjoy the holdidays with your young'ins; as the clock will move too fast and soon enough they will be taking drivers ed. classes.
    Catch
  • Chuck Jaffe: The Fund Mis-Manager of the Year — And More Lump Of Coal Awards
    Do not own this but have considered.....and glad we did not.
    VILLX was near the top of the moderate/balanced pile for several years and took a wrong turn somewhere this year. A -3.17% YTD. Bark, bark, bark.....
    M* performance link
  • Is It Time to Throttle Back Equities?
    @expatsp. Me too with BB. FAAFX a drag. WBMIX did not help either...neither did SIGIX, although it at least nicely beat in its category, as is usual for Mr. Foster.
    One day the Great Pumpkin will come to we loyal investors in FAAFX =).
    Fortunately, DODGX, did well. I remain fully invested (thanks for AKAFlack) versus DODGX/DODIX split...and will stay so as long as 10-mo SMA is positive.
    And, had couple individual stocks that have done well. Thanks to Ted for helping me double down on BAC. Ditto to Scott wrt/OAK. AA and HCP also had good years.
    Honestly, thanks to all the support and guidance I get from the board.
    To 2015...a new season.
    Go Yanks!
    c
  • In Defense Of Advisors Who Sell Variable Annuities
    We have had particularly difficult time dealing with TIAA-CREF. They always treat client dollars as their own. The TIAA portion is very problematic to deal with, since clients rarely understand that this cannot be rolled over at retirement. It has to be annuitized or taken over a 10-year period. Unfortunately, many 403b, 457, etc participants put most of their dollars in the TIAA portion of their plan. The other issue is that if someone has worked at several different schools, churches, government entities over their career, they will have separate TIAA-CREF accounts for each entity, each with slightly different rules depending on what the entity negotiated with TIAA-CREF. Tracking these is often difficult for individuals, and the statements from TIAA-CREF are not particularly helpful, either.
    Regarding your other thoughts, since most client annuity contracts are for retirement accounts (nothing like putting a tax-deferred contract inside a tax-deferred account!), we hardly ever annuitze these, always doing a rollover to Schwab or Fidelity IRA. Those few contracts that need to be kept in an annuity format can usually be dealt with in an appropriate manner. Often the client does not need the dollars for income at all, and will continue to put off taking dollars as long as they can. Others might be 1035 to an immediate fixed annuity if the rate is acceptable and the company is good. Unlike those who make a living selling annuities, we find there are many options to consider.
    Jefferson National's Monument Advisor has been a godsend for fee-only companies, and it has done a very good job of working with firms to set up accounts for downloading and monitoring. The 400+ investment options are certainly more than needed and have many very good managers/funds. No commission, no surrender period, and a simple $240 annual fee are very attractive. For a $100,000 contract, this amounts to an annual 0.24%, which is similar to Vanguard and Fidelity, lower than Schwab. Truth to tell, there is no perfect annuity, just as there is no perfect investment of any kind.
  • The Breakfast Briefing: U.S.
    FYI: Once again, the Dow is on the verge of 18000, which would be quite the capper on what’s been a massive, multiyear rally. But the rally has been rocky for the past several months, and the volatility in the markets may only get worse when the calendar turns.
    Regards,
    Ted
    http://blogs.wsj.com/moneybeat/2014/12/23/morning-moneybeat-prepare-for-greater-gyrations/tab/print/
  • Is It Time to Throttle Back Equities?
    Hi JohnChisum, expatsp, kevindow, Catch22 and others that my follow with comment,
    Thanks for stopping by and making comment. The reason I made this post is I am looking out towards mid January when fourth quarter 2014 earnings will began to be reported. I am thinking the outlook for the energy sector will disappoint for many investors which will weigh on the overall equity markets and we will perhaps see a good dip, pullback or even a downdraft present itself. There is always perhaps a not so associated with this call.
    Since, I am currently overweight equities from my neutral position I am thinking of trimming after we get into January as I am looking for another percent or so to come for the S&P 500 Index before year end. I am thinking the first week on January will also be a good week but after that I am thinking things will slow and that’s when I am thinking of trimming.
    I can do this in steps as the market moves upward, or downward, or in bulk at the time of my choosing. I also think that for 2015 we will perhaps see another 8% gain on the Index although the ride will be a bumpy one. With this anticipated volatility I plan to make some more special spiff investment positions and to profit form this I will have to buy low during market declines and sell high towards market peaks. I plan to do this in a tax deferred account and in funds that I can buy at nav. Some might say this is market timming (as Dex at first did) ... however, by my defination it is not as I am not a day trader nor am I buying inapporiately in mutual funds after the markets have closed and outside of what is allowed by fund prospectus. This type of investment strategy would be called by some as simply playing the swing.
    You now have my playbook exposed prior to the anticipated events as some have said I have failed to do in the past in posting past successes. I do this in the spirit of helping others with some insight to my thinking. However, one should do their own thinking and not rely on mine because I have been know, at times, to have missed calls. And, yes, this is hard to do as the market changes and at times is not in concert with my playbook. And, with this I have to remain flexible. But, if one fails to plan then they have planned to fail.
    Wishing all the best for the Holiday Season and most of all … Merry Christmas!
    Old_Skeet
  • Chuck Jaffe: The Fund Mis-Manager of the Year — And More Lump Of Coal Awards
    FYI: I once visited friends for the holiday where the mom in the family insisted that the best thing about the season was “seconds,” meaning that there was always a second helping of everything good for those who wanted it.
    Today, there’s a second helping of something bad.
    It’s part two of my 19th annual Lump of Coal Awards, my two-week holiday tradition of easing Santa’s burden by singling out the bad boys and girls of the mutual-fund industry who deserve nothing more than an inky chunk of carbon in their Christmas stockings.
    Regards,
    Ted
    http://www.marketwatch.com/story/the-fund-mis-manager-of-the-year-and-more-lump-of-coal-awards-2014-12-23/print
  • Is It Time to Throttle Back Equities?
    @Charles: Thanks for sharing your (relative) pain, I too am way behind the S&P this year after a few years outperforming. Fairholme hit me hard, and great performance from Primecap and decent performance from Bridgeway (my other two big positions) weren't enough to compensate. My foreign funds (ARTKX, SFGIX, GPIOX) outpeformed their benchmarks but underperformed, of course, the S&P.
    Getting back to this general topic, I intend to remain close to fully invested in equities. The economy seems to be picking up speed, not slowing down, so I don't see any reason for a bear market any time soon. And as to the inevitable 5-10% corrections, I've learned that I'm not smart enough to time those, though I do have a little dry powder just in case some bargains appear.
  • Schwab ETFs Say No To Capital Gains
    FYI: Charles Schwab (NYSE: SCHW), the discount brokerage giant and eighth-largest U.S. issuer of exchange traded funds, said Monday none of its 21 ETFs will distribute capital gains this year marking the fifth consecutive year none of the firm’s ETFs have hit investors with capital gains distributions.
    Regards,
    Ted
    http://www.etftrends.com/2014/12/schwab-etfs-say-no-to-capital-gains/
  • Is It Time to Throttle Back Equities?
    Here's AGG...good year, despite the hearsay about interest rates rising...
    image